Literature DB >> 11587766

RNase P: from biological function to biotechnological applications.

C Cobaleda1, I Sánchez-García.   

Abstract

The M1 RNA subunit of Escherichia coli RNase P is a ribozyme responsible for the catalytic activity of the complex. It removes the 5' leader sequence from tRNA precursors to form mature tRNAs. M1 recognizes its target mainly on the basis of its structure and this allows the design of modified ribozymes engineered to destroy other molecules without the need for special sequences in the targeted mRNAs. M1 is thus an ideal tool to eliminate the tumourigenic chimeric messengers created after chromosomal translocations. These results have direct implications for cancer therapeutics and molecular biology in general.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587766     DOI: 10.1016/S0167-7799(01)01741-3

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  4 in total

1.  Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.

Authors:  Gunter Kraus; Rebeca Geffin; Gina Spruill; Andrea K Young; Rachel Seivright; Diana Cardona; Jennifer Burzawa; H James Hnatyszyn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 2.  Structure and functional properties of prokaryotic small noncoding RNAs.

Authors:  K Mikulík
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

3.  Rapid selection of accessible and cleavable sites in RNA by Escherichia coli RNase P and random external guide sequences.

Authors:  Eirik W Lundblad; Gaoping Xiao; Jae-Hyeong Ko; Sidney Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-08       Impact factor: 11.205

4.  Anticancer Activity of Reconstituted Ribonuclease S-Decorated Artificial Viral Capsid.

Authors:  Yingbing Liang; Hiroto Furukawa; Kentarou Sakamoto; Hiroshi Inaba; Kazunori Matsuura
Journal:  Chembiochem       Date:  2022-06-21       Impact factor: 3.461

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.